Search results

Order by most recent / most popular / relevance

Results: 1-10 of 49

AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply

Pfizer v. Pharmascience, merits of NOC proceeding

Gowling Lafleur Henderson LLP
-
Canada
-
January 20 2010

The Court granted prohibition to Pfizer and found that Pharmascience’s allegations of invalidity were not justified

Sanofi v. ApotexNovopharm

Gowling Lafleur Henderson LLP
-
Canada
-
July 27 2009

The Court found the patent infringed, but invalid and thus dismissed two actions for infringement

Eli Lilly v. Apotex

Gowling Lafleur Henderson LLP
-
Canada
-
May 4 2009

In the underlying decision on the merits, the Federal Court dismissed the application on the basis that the allegation as to a lack of sound prediction because the patent lacks adequate disclosure was justified

Pfizer v. Apotex

Gowling Lafleur Henderson LLP
-
Canada
-
April 7 2009

The Court upheld the decision of the Prothonotary refusing further production of ANDS documents

Federal Court of Appeal upholds denial of innovator profits and refuses to grant damages for future lost market share in first case under s. 8 of the PM(NOC) Regulations

Gowling Lafleur Henderson LLP
-
Canada
-
June 5 2009

In September 2008, the Federal Court released its first decision interpreting s. 8 of the PM(NOC) Regulations

Aventis v. Pharmascience; motion to set aside a previous order of prohibition; 2009 FC 915; ramipril; September 15, 2009

Gowling Lafleur Henderson LLP
-
Canada
-
September 30 2009

Pharmascience had previously sent an Notice of Allegation (NOA) with respect to a patent to Aventis, resulting in a full hearing and appeal, concluding with an order of prohibition

Janssen-Ortho v. Apotex; motion for a stay; 2009 FCA 250; tramadol and acetaminophen; August 20, 2009

Gowling Lafleur Henderson LLP
-
Canada
-
September 30 2009

In the Courts below, Apotex brought a motion to dismiss the application

Apotex v. Pfizer

Gowling Lafleur Henderson LLP
-
Canada
-
March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent

Solvay v. Canada (Minister of Health)

Gowling Lafleur Henderson LLP
-
Canada
-
March 4 2009

The Court upheld the decision of the Minister refusing to list a patent on the Patent Register

next >